Parth Upadhyaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Parth Upadhyaya has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Amie W Hsia
Stroke Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, 10 Center Dr., Building 10, Room B1D733, Bethesda, MD 20892, USA; Department of Neurology, Georgetown University School of Medicine, Washington, D.C., USA; Comprehensive Stroke Center, MedStar Washington Hospital Center, Washington, D.C., USA
1 shared publicationAmit Mehta
Department of Neurology, Georgetown University School of Medicine, Washington, D.C., USA
1 shared publicationAnthony C. Torres
Valley Hospital Medical Center, 620 Shadow Lane, Las Vegas, NV 89106, United States
1 shared publicationBrendan Kelley
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX
1 shared publication- Conny Tran
University of Texas Southwestern Medical Center, Dallas, TX, USA; Parkland Memorial Hospital, Dallas, TX, USA
1 shared publication Erica Jones
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX
1 shared publication
Latest Publications
- 28 January 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (2) , e210258
Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy
Cerebral microbleeds (cMBs) are common imaging findings in conditions related to cerebral amyloid angiopathy (CAA). Blood-brain barrier (BBB) leakage is considered pivotal in their pathogenesis. This study investigates the potential role of cerebral microenhancement (cME) as an imaging biomarker on 3D T1 black-blood MRI (BB-MRI) for BBB rupture, predicting the formation of cMBs in inflammatory CAA variants. A retrospective review was conducted on biopsy-confirmed cases of CAA-related inflammation (CAA-ri) and amyloid-beta-related angiitis (ABRA) from the UT Southwestern Medical Center's BB-MRI registry (2014-2022). Subjects underwent 3D T1 BB MRI and susceptibility-weighted imaging. The presence and progression of cMEs and cMBs were assessed. A total of 5 subjects (1 CAA-ri, 4 ABRA) were identified. Frequent cMEs on 3D T1 BB MRI scans preceded cMB formation, particularly in subjects with the ApoE ɛ4/4 genotype experiencing a refractory clinical course. Stable subjects had fewer cMEs and cMBs. The presence of cME before cMB suggests their potential as a biomarker for cMB formation. The findings align with the hypothesis that BBB rupture and focal inflammation are critical in cMB pathogenesis. Further validation of 3D T1 BB MRI as an assessment tool for cMB formation in inflammatory CAA based on clinicoradiologic diagnosis and noninflammatory CAA could enhance monitoring and treatment strategies.
- 28 January 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (2) , e210258
Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy
Cerebral microbleeds (cMBs) are common imaging findings in conditions related to cerebral amyloid angiopathy (CAA). Blood-brain barrier (BBB) leakage is considered pivotal in their pathogenesis. This study investigates the potential role of cerebral microenhancement (cME) as an imaging biomarker on 3D T1 black-blood MRI (BB-MRI) for BBB rupture, predicting the formation of cMBs in inflammatory CAA variants. A retrospective review was conducted on biopsy-confirmed cases of CAA-related inflammation (CAA-ri) and amyloid-beta-related angiitis (ABRA) from the UT Southwestern Medical Center's BB-MRI registry (2014-2022). Subjects underwent 3D T1 BB MRI and susceptibility-weighted imaging. The presence and progression of cMEs and cMBs were assessed. A total of 5 subjects (1 CAA-ri, 4 ABRA) were identified. Frequent cMEs on 3D T1 BB MRI scans preceded cMB formation, particularly in subjects with the ApoE ɛ4/4 genotype experiencing a refractory clinical course. Stable subjects had fewer cMEs and cMBs. The presence of cME before cMB suggests their potential as a biomarker for cMB formation. The findings align with the hypothesis that BBB rupture and focal inflammation are critical in cMB pathogenesis. Further validation of 3D T1 BB MRI as an assessment tool for cMB formation in inflammatory CAA based on clinicoradiologic diagnosis and noninflammatory CAA could enhance monitoring and treatment strategies.
- 27 July 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (9) , 107271
Episodic stuttering as the presenting manifestation of acute ischemic stroke: A case report and systematic literature review
- 27 July 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (9) , 107271
Episodic stuttering as the presenting manifestation of acute ischemic stroke: A case report and systematic literature review
- 24 November 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (1) , 106870
Good outcome associated with blood-brain barrier disruption and lower blood pressure after endovascular therapy
- 24 November 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (1) , 106870
Good outcome associated with blood-brain barrier disruption and lower blood pressure after endovascular therapy
- Open Access
- 1 December 2017
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 10, 155-158
Dural AVM (dAVM) in Cowden disease
- 1 December 2017
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 10, 155-158
Open AccessDural AVM (dAVM) in Cowden disease